glutathione binding to iron Controlling entry into mitochondria: potential roles for SLC25A39 in health and (treatment of) disease Glutaredoxin catalysis requires two distinct

A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice

Moxibustion protects against ulcerative colitis, post-inflammatory irritable bowel syndrome, and chronic exercise-induced fatigue (Li et al

A3 receptor antagonists lower IOP by preventing adenosine-induced activation of Cl- channels in ciliary epithelial cells, while A2A receptor activation in Schlemm's canal cells can have bidirectional effects on IOP (90, 92)

This peptide is considered a powerhouse due to its versatility across multiple systems, including musculoskeletal, gastrointestinal, neurological, and cardiovascular